Enhancing U.S. Surveillance of Laboratory Confirmed SARS-CoV-2, Influenza, and other Respiratory Viruses through a Network of Emergency Departments

Please note this is for NCIRD- Influenza Division

This is a Sources Sought notice. This is not a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of qualified sources to perform a potential requirement.

Purpose and Objectives: The Centers for Disease Control and Prevention (CDC)-NCIRD/ Influenza Division, is seeking to assess the feasibility of creating a national U.S. network by establishing the collection and reporting of weekly lab-confirmed respiratory virus surveillance data from ED patients, and obtaining follow up information to determine patient disposition.

These data will provide CDC and states with critical information necessary to determine rates of respiratory illness in ED settings and the percent of specimens testing positive for SARS-CoV-2, influenza, or other respiratory viruses in both hospitalized and non-hospitalized ED patients. Please see draft statement of work attached to this notice.

It is anticipated that the Period of Performance of this contract will be from September 15, 2024 to September 14, 2028. This period of performance is inclusive of a base and three (3) option periods.

Capability Statement/Information Sought: Interested firms are requested to submit a capability statement, which shall include documentation of the ability to perform the requirements and information on previous successfully completed contracts for the same type of work. Please note that capability statems that only include marketing material will not be considered or reviewed.

The respondent must also provide their DUNS number, organization name, address, points of contact, and size and type of business (e.g., 8(a), HubZone, etc., pursuant to the applicable NAICS code), and any other information that may be helpful in developing or finalizing the acquisition requirements. Please limit your responses to five (5) pages. All responses to this notice must be submitted electronically. Facsimile responses will not be accepted. Please submit responses to Ada Torres Vega, Contract Specialist, at cbp0@cdc.gov.

Disclaimer and Important Notes: This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice.

The Government will not be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Submissions will not be returned.

Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response.